Maeda K - Search Results

1

Confirmation of a relationship between reduced auditory P300 amplitude and thought disorder in schizophrenia.

Kirihara K, Araki T, Kasai K, Maeda K, Hata A, Uetsuki M, Yamasue H, Rogers MA, Kato N, Iwanami A. Kirihara K, et al. Among authors: maeda k. Schizophr Res. 2005 Dec 15;80(2-3):197-201. doi: 10.1016/j.schres.2005.08.003. Epub 2005 Sep 19. Schizophr Res. 2005. PMID: 16169707

2

Electrophysiological indices associated with social functioning outcome in schizophrenia: a 5-year follow-up study.

Maeda K, Nakagome K, Kasai K, Ikebuchi E, Iwanami A, Kudoh N, Araki T, Fukuda M. Maeda K, et al. Neurosci Res. 2005 Feb;51(2):215-8. doi: 10.1016/j.neures.2004.11.001. Neurosci Res. 2005. PMID: 15681038

3

Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia.

Maeda K, Kasai K, Watanabe A, Henomatsu K, Rogers MA, Kato N. Maeda K, et al. Psychiatr Serv. 2006 Aug;57(8):1203-5. doi: 10.1176/ps.2006.57.8.1203. Psychiatr Serv. 2006. PMID: 16870974

4

Increased positive thought disorder with illness duration in patients with schizophrenia.

Maeda K, Kasai K, Uetsuki M, Hata A, Araki T, Rogers MA, Yamasue H, Iwanami A. Maeda K, et al. Psychiatry Clin Neurosci. 2007 Dec;61(6):687-90. doi: 10.1111/j.1440-1819.2007.01730.x. Psychiatry Clin Neurosci. 2007. PMID: 18081634 Free article.

5

Community discharge of patients with schizophrenia: a Japanese experience.

Noda F, Clark C, Terada H, Hayashi N, Maeda K, Sato M, Ito K, Kitanaka J, Asai T, Nishimura T, Kushigami K, Okada K, Taniguchi Y, Mantani T. Noda F, et al. Among authors: maeda k. Psychiatr Rehabil J. 2004 Fall;28(2):143-9. doi: 10.2975/28.2004.143.149. Psychiatr Rehabil J. 2004. PMID: 15605750

6

Overproduction of PU.1 in mast cell progenitors: its effect on monocyte- and mast cell-specific gene expression.

Nishiyama C, Nishiyama M, Ito T, Masaki S, Maeda K, Masuoka N, Yamane H, Kitamura T, Ogawa H, Okumura K. Nishiyama C, et al. Among authors: maeda k. Biochem Biophys Res Commun. 2004 Jan 16;313(3):516-21. doi: 10.1016/j.bbrc.2003.11.145. Biochem Biophys Res Commun. 2004. PMID: 14697219

7

GATA-1 is required for expression of Fc{epsilon}RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow.

Nishiyama C, Ito T, Nishiyama M, Masaki S, Maeda K, Nakano N, Ng W, Fukuyama K, Yamamoto M, Okumura K, Ogawa H. Nishiyama C, et al. Among authors: maeda k. Int Immunol. 2005 Jul;17(7):847-56. doi: 10.1093/intimm/dxh278. Epub 2005 Jun 20. Int Immunol. 2005. PMID: 15967781

8

The CD300e molecule in mice is an immune-activating receptor.

Isobe M, Izawa K, Sugiuchi M, Sakanishi T, Kaitani A, Takamori A, Maehara A, Matsukawa T, Takahashi M, Yamanishi Y, Oki T, Uchida S, Uchida K, Ando T, Maeda K, Nakano N, Yagita H, Takai T, Ogawa H, Okumura K, Kitamura T, Kitaura J. Isobe M, et al. Among authors: maeda k. J Biol Chem. 2018 Mar 9;293(10):3793-3805. doi: 10.1074/jbc.RA117.000696. Epub 2018 Jan 22. J Biol Chem. 2018. PMID: 29358324 Free PMC article.

9

Regulation of human FcepsilonRI beta chain gene expression by Oct-1.

Akizawa Y, Nishiyama C, Hasegawa M, Maeda K, Nakahata T, Okumura K, Ra C, Ogawa H. Akizawa Y, et al. Among authors: maeda k. Int Immunol. 2003 May;15(5):549-56. doi: 10.1093/intimm/dxg055. Int Immunol. 2003. PMID: 12697656

10

Mast cells acquire monocyte-specific gene expression and monocyte-like morphology by overproduction of PU.1.

Ito T, Nishiyama C, Nishiyama M, Matsuda H, Maeda K, Akizawa Y, Tsuboi R, Okumura K, Ogawa H. Ito T, et al. Among authors: maeda k. J Immunol. 2005 Jan 1;174(1):376-83. doi: 10.4049/jimmunol.174.1.376. J Immunol. 2005. PMID: 15611261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,958 results

Search Page

Filters